Portfolio company Tioga Cardiovascular announced first trans-septal human implantations of its Luna transcatheter mitral valve replacement system.
Tioga Cardiovascular is focused on developing innovative solutions for mitral valve replacement, specifically targeting mitral regurgitation (MR) with their investigational Tioga TMVR System, which features a unique valve and anchor design aimed at minimizing patient exclusions
Tioga Cardiovascular is focused on developing innovative solutions for mitral valve replacement, specifically targeting mitral regurgitation (MR) with their investigational Tioga TMVR System, which features a unique valve and anchor design aimed at minimizing patient exclusions.